Market Snapshot

BSE Sensex: 78151.45 1.25%
BSE 500: 36505.4 0.48%
BSE 200: 11352.01 0.69%
BSE 100: 25871.39 0.93%
BSE BANKEX: 66194.59 1.58%
BSE IT: 28226.33 1.38%
Nifty 50: 24334.3 1.09%
Nifty 500: 23336.3 0.45%
Nifty 200: 14014.15 0.61%
Nifty 100: 25327.65 0.87%
Nifty Midcap 100: 62428.05 -0.41%
Nifty Small 100: 19296.3 -0.21%
Nifty IT: 29226.6 1.75%
Nifty PSU Bank: 8381.75 0.41%

News:

HDFC Bank Q1 PAT rises 5% YoY ...
ICICI Bank Q1 PAT rises 16% Yo...
Tata Technologies Q1 PAT grows...
India Cements reports turnarou...
Kotak Mahindra Bank Q1 PAT cli...

Nectar Lifescience Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

17 Jul 2026 | 03:59 PM

10.80

-0.24 (-2.17%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-37.72%

Return (1Y)

Underperformed BSE Healthcare by 47.36%
More Volatile

3.57%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.72%
Not so consistent

5/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

News & Announcements

Nectar Lifescience reports consolidated net loss of Rs 67.92 crore in the March 2026 quarter
47 days ago

Nectar Lifescience reports consolidated net loss of Rs 67.92 crore in the March 2026 quarter

01 - Jun - 2026 12:00 | 47 days ago

Net Loss of Nectar Lifescience reported to Rs 67.92 crore in the quarter ended March 2026 as against net loss of Rs 130.09 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 292.89 crore in the year ended March 2026 as against net loss of Rs 113.68 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 as against Rs 21.32 crore during the previous year ended March 2025.
Powered by Capital Market - Live News
Nectar Lifescience to discuss results
53 days ago

Nectar Lifescience to discuss results

26 - May - 2026 12:00 | 53 days ago

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 30 May 2026.
Nectar Lifescience consolidated net profit rises 82.02% in the December 2025 quarter
175 days ago

Nectar Lifescience consolidated net profit rises 82.02% in the December 2025 quarter

24 - Jan - 2026 12:00 | 175 days ago

Net profit of Nectar Lifescience rose 82.02% to Rs 14.27 crore in the quarter ended December 2025 as against Rs 7.84 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.
Powered by Capital Market - Live News
Nectar Lifescience announces board meeting date
180 days ago

Nectar Lifescience announces board meeting date

19 - Jan - 2026 12:00 | 180 days ago

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 23 January 2026.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Nectar Lifescience Ltd has decreased by -16.8% since past 3 Months
MF shareholding in Nectar Lifescience Ltd has decreased by -16.67% since past 3 Months
FII shareholding in Nectar Lifescience Ltd has decreased by -38.47% since past 1 Year
Promoter shareholding in Nectar Lifescience Ltd has increased by 16.41% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Nectar Lifescience Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

10.80 -0.24 (-2.17%)

News & Announcements

Price vs Volume

Stock Trivia

Nectar Lifescience Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

10.80

-0.24 (-2.17%)